US FDA Clears Key Mylan Inc. Plant, Closes Probe

Bookmark and Share

Reuters -- The U.S. Food and Drug Administration said on Thursday it completed a probe into a key Mylan Inc (MYL.O) manufacturing plant and found no deficiencies, clearing an issue that has hung over the world's No. 3 generic drugmaker. Its shares rose about 4 percent.

Back to news